CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Glitazone-mediated vascular protection requires high mobility group A1 protein – a new PPARgamma coregulator
DOI 10.1055/s-0030-1254012
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Bloch, A Prock, F Paonessa, A Foryst-Ludwig, K Kappert, J Spranger, T Unger, A Fusco, D Sedding, A Brunetti, U Kintscher
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Previously we have shown that the chromatin-modifying high mobility group A1 protein (HMGA1) is required for Peroxisome Proliferator-activated Receptor gamma (PPARgamma)-mediated transrepression in vascular smooth muscle cells (VSMCs). The aim of the present study was to characterize the in-vivo relevance of HMGA1 in PPARgamma-mediated beneficial effects after vascular injury. The effect of pioglitazone (pio) treatm…
Zitieren
Zitierempfehlung
M Bloch, A Prock, F Paonessa, A Foryst-Ludwig, K Kappert, J Spranger, T Unger, A Fusco, D Sedding, A Brunetti, U Kintscher (2010) Glitazone-mediated vascular protection requires high mobility group A1 protein – a new PPARgamma coregulator. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0030-1254012
Mit CareLit weiterarbeiten